Amit V. Khera

Nov 16, 2024 | healio.com | Regina Schaffer |Richard Smith |Amit V. Khera

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: The American Heart Association is marking its 100th anniversary this year. Special sessions will highlight advances in CVD research and AHA’s history.

Jul 29, 2024 | medrxiv.org | Mary McGowan |Chao Xing |Amit V. Khera |Chun-Yuan Huang

ZA research funding from US Department of Defense, National Institute of Health, and Ionis Pharmaceuticals; Site Primary Investigator for Ionis Pharmaceuticals. AK: research funding from National Institute of HealthnoneI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Nov 10, 2023 | healio.com | Erik Swain |Richard Smith |Amit V. Khera

You've successfully added Cardiology: Practice Management to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: The American Heart Association Scientific Sessions will take place in Philadelphia from Nov. 11 to 13.

Jul 28, 2023 | healio.com | Regina Schaffer |Amit V. Khera

Source/Disclosures Source: Khera A. Session 8: Novel Approaches to Opportunistic Screening. Presented at: American Society for Preventive Cardiology Congress on CVD Prevention; July 21-23, 2023; Arlington, Texas. Disclosures: Khera reports no relevant financial disclosures. Source/Disclosures Source: Khera A. Session 8: Novel Approaches to Opportunistic Screening.

Jun 8, 2023 | nature.com | Jeffrey D. Wall |Radha Venkatesan |John Fang |Jacqueline Robinson |Lukas Forer |Minxian Wang | +11 more

Our research was conducted in compliance with the ethical committees associated with each of the sampling sites. Specific details are provided in Supplementary Note 1. SamplesWe utilized a combination of genomes from previously published studies8,9,10,11,12,13, newly sequenced genomes from 1000 Genomes Project samples, and newly sequenced genomes from several ongoing genetic studies in South Asia. Further information on the samples is contained in Supplementary Note 1 and Supplementary Data 1.